These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29082715)

  • 1. [Advance of gene-modified non-human primate models].
    Liu Z; Cai Y; Sun Q
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1665-1673. PubMed ID: 29082715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9.
    Koo T; Lee J; Kim JS
    Mol Cells; 2015 Jun; 38(6):475-81. PubMed ID: 25985872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Editing of Monkey.
    Liu Z; Cai Y; Sun Q
    Methods Mol Biol; 2017; 1630():141-152. PubMed ID: 28643256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome editing and the next generation of antiviral therapy.
    Stone D; Niyonzima N; Jerome KR
    Hum Genet; 2016 Sep; 135(9):1071-82. PubMed ID: 27272125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To CRISPR and beyond: the evolution of genome editing in stem cells.
    Chen KY; Knoepfler PS
    Regen Med; 2016 Dec; 11(8):801-816. PubMed ID: 27905217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental history and application of CRISPR in human disease.
    Liang P; Zhang X; Chen Y; Huang J
    J Gene Med; 2017 Jun; 19(6-7):. PubMed ID: 28623876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advance and application in the gene therapy of gene editing technologies].
    Ren YX; Xiao RD; Lou XM; Fang XD
    Yi Chuan; 2019 Jan; 41(1):18-27. PubMed ID: 30686782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of genetically-engineered animals using engineered endonucleases.
    Lee JG; Sung YH; Baek IJ
    Arch Pharm Res; 2018 Sep; 41(9):885-897. PubMed ID: 29777358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases.
    Ishida K; Gee P; Hotta A
    Int J Mol Sci; 2015 Oct; 16(10):24751-71. PubMed ID: 26501275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of CRISPR RNA-guided genome editing.
    Koo T; Kim JS
    Brief Funct Genomics; 2017 Jan; 16(1):38-45. PubMed ID: 27562951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators.
    Chakraborty C; Teoh SL; Das S
    Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Editing for the Study of Cardiovascular Diseases.
    Chadwick AC; Musunuru K
    Curr Cardiol Rep; 2017 Mar; 19(3):22. PubMed ID: 28220462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basics and applications of genome editing technology].
    Yamamoto T; Sakamoto N
    Rinsho Ketsueki; 2016; 57(10):1869-1873. PubMed ID: 27725582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.
    He Z; Kee K
    Methods Mol Biol; 2017; 1498():153-162. PubMed ID: 27709574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.